安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Paxlovid for COVID-19: Uses, Side Effects, Interactions Dose - Drugs. com
Paxlovid is an antiviral treatment used for COVID-19 to lower the risk of severe COVID-19, including hospitalization or death Paxlovid works by helping stop the virus from multiplying, which improves COVID-19 symptoms and reduces hospitalizations and deaths in high-risk patients
- Dosing | PAXLOVID® (nirmatrelvir tablets; ritonavir tablets)
Learn about PAXLOVID® dosing and administration, including standard dose and reduced dose for patients with moderate renal impairment See risks benefits
- How To Take PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)
What is PAXLOVID? PAXLOVID is a prescription medicine used to treat mild-to-moderate coronavirus disease 2019 (COVID‑19) in adults who are at high risk for progression to severe COVID‑19, including hospitalization or death
- Dosing | PAXLOVID® (nirmatrelvir tablets; ritonavir tablets)
Because nirmatrelvir is coadministered with ritonavir, there may be a risk of HIV-1 developing resistance to HIV protease inhibitors in individuals with uncontrolled or undiagnosed HIV-1 infection
- A Quick Guide To Paxlovid Dosages - GoodRx
Paxlovid (nirmatrelvir ritonavir) is an oral antiviral medication that’s FDA approved to treat people at high risk of developing severe illness from COVID-19 Adults and children ages 12 and older with mild-to-moderate COVID who weigh at least 88 lbs (40 kg) are eligible to take it
- HKG LPD Nirmatrelvir, Ritonavir - Paxlovid - Pfizer
PAXLOVID is indicated for the treatment of mild-to-moderate coronavirus disease 2019 (COVID-19) in adults who are at high risk for progression to severe COVID-19, including hospitalization or death PAXLOVID is not approved for use as pre-exposure or post-exposure prophylaxis for prevention of COVID-19 [see Clinical Studies (13 3)]
- label - Food and Drug Administration
PAXLOVID includes ritonavir, a strong CYP3A inhibitor, which may lead to greater exposure of certain concomitant medications, resulting in potentially severe, life-threatening, or fatal events
- Paxlovid (nirmatrelvir ritonavir) dosing, indications, interactions . . .
Patients with moderate renal failure (10 doses): 150 mg nirmatrelvir and 100 mg ritonavir: Each daily blister card contains 2 nirmatrelvir tablets (150-mg) and 2 ritonavir tablets (100-mg)
|
|
|